chr17-35148430-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting
The NM_001267052.2(UNC45B):c.167C>T(p.Thr56Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,613,422 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 18/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001267052.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UNC45B | NM_001267052.2 | c.167C>T | p.Thr56Met | missense_variant, splice_region_variant | 2/20 | ENST00000394570.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UNC45B | ENST00000394570.7 | c.167C>T | p.Thr56Met | missense_variant, splice_region_variant | 2/20 | 1 | NM_001267052.2 | P4 | |
UNC45B | ENST00000591048.2 | c.167C>T | p.Thr56Met | missense_variant, splice_region_variant | 1/17 | 1 | |||
UNC45B | ENST00000268876.9 | c.167C>T | p.Thr56Met | missense_variant, splice_region_variant | 2/20 | 5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000455 AC: 113AN: 248484Hom.: 1 AF XY: 0.000601 AC XY: 81AN XY: 134688
GnomAD4 exome AF: 0.000204 AC: 298AN: 1461174Hom.: 5 Cov.: 31 AF XY: 0.000271 AC XY: 197AN XY: 726852
GnomAD4 genome AF: 0.000118 AC: 18AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74444
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at